Clinical practice guidelines on assessment and management of substance abuse disorder in children and adolescents

Navendu Gaur, Manaswi Gautam, Shubh Mohan Singh, V. Venkatesh Raju, Siddharth Sarkar

Indian Journal of Psychiatry · 2019 · 10 citations · 4 references

DOIFull text

Open access

Concepts

Abstract

INTRODUCTION Today's youth are tomorrow's future and hence it is very important to formulate the clinical practice guidelines for substance abuse disorder in children and adolescents. The previous guidelines were published in 2008, so it was of paramount importance to update the scientific information to guide management in recent times. According to the Census of India, 2011, adolescents (10–19 years) constitute one-fifth (20.91%) of the Indian population. The first nation-wide survey on children (5–18 years) conducted under the auspices of the National Commission for Protection of Child Rights (2013) at 135 sites across 27 states and 2 union Territories provides us with significant insights as to the magnitude and pattern of drug menace in this age group. Most children had used any one or more of the substances in their lifetimes with tobacco and alcohol leading the charts followed by cannabis, inhalant, opioids, sedatives, and heroin/smack; and there is progression from licit to illicit substances. The mean age at onset was 12.3 years with increasing age associated with increased use of illicit drugs. The type of substance preference varies in different geographical regions. Out-of-school and street children have an earlier onset and more dysfunction and almost half of them are working in unskilled jobs. It is to be noted that among these more than two-third had never sought treatment. The presentation of substance use problem differs in adults and adolescents as shown in Table 1. It is quite reasonable to say that adolescents will have much better prognosis if evidence-based treatment programs are designed keeping in mind these very fundamental differences and needs in mind.Table 1: Clinically significant differentiating characteristics of adolescent substance abusers from adult substance abusersBefore implementing the current guidelines in toto, one should be acutely aware of the fact that evidence regarding substance use disorder (SUD) in adolescence is nonexisting (India in general and Indian children and adolescents in particular). Though we may speculate that cultural and ethnic factors may influence the treatment process and outcomes, the evidence related to this aspect is lacking. The primary goal (both in short-term and long-term) of SUDs management in adolescents is to achieve and maintain abstinence from substance use. While trying to achieve the ultimate, harm reduction may be an intermediate implicit (never explicit) goal of treatment. The treatment goal should not only include substance control but a range of rehabilitative measures too. This will not only improve psychosocial functioning but will also help in achieving improved outcomes in terms of achieving and maintaining abstinence. METHODOLOGY Review articles and various guidelines published till 2018 were searched. A thorough search in Google, Google scholar, and PubMed was made with search words/phrases such as Management/treatment/intervention of substance/alcohol/tobacco/cigarette/inhalant/opioids/heroin/stimulants/benzodiazepines/use/abuse/addictions in children and/or adolescence with special emphasis for articles published after 2010. General considerations for the management of substance use disorders in children and adolescents Ethical considerations specific to children and adolescents need to be considered Setting for the treatment needs to be decided based on clinical features Inpatient treatment should be reserved for patients with severe dependence, longer duration of use, multiple failed abstinent attempts in the past, significant health complications, concurrent use of multiple other substances, substantial problems at home or school, absent/minimal family support, distance from care providers, and familial issues that interfere with care process In outpatient treatment, frequency and duration of sessions may vary depending on patient characteristics and individualized goals. Management can be conceptualized into Short-term and long-term Pharmacological and nonpharmacological. Short-term Assessment: A detailed work up of patients with elaborate history of substance use and its medical and psychological complications needs to be done. History about family, school, work, sexual, living conditions, temperament, comorbid conditions such as attention deficit/hyperactivity disorders (ADHD) and conduct disorder needs to be taken. General physical examination, systemic examination, and a mental state examination need to be done covering assessment of behavior, speech, affect, thought, and perceptual disturbances. Cognitive functions such as consciousness, orientation, memory, intelligence, abstract thinking, and judgment need to be checked. Motivation to quit substance, to be assessed by Diclemente and Prochaska's stages of change and finally insight of patient about his problems needs to be assessed. The motivational interviewing technique can be used while eliciting history to enhance person's motivation Screening to be done based on clinical pointers for suspected substance use, marked decline in upkeep, absenteeism or truancy from school, decreasing school performance, impairment in cognitive function (like attention or memory), or recent change in behavior. Diagnosis should be established as per ICD-10 classificatory system Investigation: Apart from routine investigation, urine screening for other substance use, serology for viral markers in case of high risk behaviors and other special investigation as per associated physical comorbidities can be considered. It helps to have baselines investigations for comparison with follow-up investigations as well as to choose medication for treatment (especially liver and renal function tests). They can also help in facilitating a change in behavior or for influence them to consider referral for treatment. General substance withdrawal rating pro forma and rating scale of substance and/or behavior-related problems in terms of (health, education, finance, legal, sexual, family, and social) are helpful for problem severity assessment, making decision with regard to treatment and assessing the progress of treatment The developmental appropriateness is a prerequisite for the instruments before applying them to adolescents. No psychometric instrument has been demonstrated to be consistently culture sensitive across all ethnicities but, at the same time, existing data fail to indicate any such need Appropriate consultation with medical specialist as and when required The management of intoxication, withdrawal and dependence of substance has a general application of both pharmacological and nonpharmacological measures in combination (though specificities exist for individual substance use as per the properties of the substance). Long-term Once stabilized from acute crisis (intoxication/withdrawal symptoms), it is essential to have a prophylaxis for lapse and relapse in long-term Harm minimization is also an important concept if complete abstinence is in question for long-term Prophylaxis mainly is talked in sense of pharmacological treatment like naltrexone (NTX) for opioids and disulfiram (DSF)/NTX for alcohol Nonpharmacological measures, where available, may be considered as a part of long-term treatment and prophylaxis involving relapse prevention counseling or therapy, group sessions, family sessions A special emphasis is given to formal engagement of patient into treatment net as long as possible considering the chronic nature of SUDs with high rates of relapse Hence, active surveillance strategy should be implemented with help sought from psychiatric social worker where available, to ensure regular follow-ups enabling long-term engagement and better outcomes The evidence-based regarding pharmacotherapy of SUD in children and adolescents is scanty. Therefore, any use of medications in this population is subject to clinical judgment and psychosocial treatments should be given a priority over them wherever and whenever feasible. Nonpharmacological measures also emphasize on wide range of services Psychoeducation of patient and family with special emphasis on harm minimization. For example, not to use inhalants when no one is around, or in a enclosed space, or when required to drive after use of inhalant, or while smoking/ being near a lit cigarette or flames, or when have accrued significant physical exertion. Brief interventions (BI): A common approach to the delivery of BIs is the FRAMES model developed by Miller and Sanchez based on the motivational interviewing style. FRAMES is an acronym for the elements of behavioral intervention, and includes providing feedback, encouraging the patient to take responsibility, advising to make change to behavior, discussing a menu of options for change, providing empathy for the condition of the patient, and supporting self for the Motivation This Miller and model specific interviewing to help the patient work and to the of is in and help the patient to the and of behavior. is as the patient is to his or and options while that it is the decision to interviewing sessions with adolescents as an before a more prevention has been shown to improve the outcomes in are primary of in cognitive and behavioral are and of is to be done individual and group has been shown to be in of SUD that include cannabis, and and about and programs that are used with adolescents are may behavior the developed such and adolescents may not be for programs to developmental characteristics and issues to alcohol use disorders among adolescents. be considered for patients for is not management It includes and It providing patients in to enhance behaviors like abstinent to substances. It has been shown to be in opioids, and dependence approach This outpatient a range of and and to make substance use than use This is and alcohol The In this a is for engagement in treatment of and them to achieve abstinence. factors a significant in adolescent various in adolescents like the therapy, family therapy, family and family high among adolescents a in engagement of the patient and of the family is on into school and school issues and This for children into the treatment and has been for street children This includes to to children to be of of This be more for chronic use this substance and where other treatment options have not for street children for and of comorbid conditions conduct disorder and disorders need to be to improve and long-term of the management psychiatric disorders with of substance use, and specific medications are not required when a to self or or the are for management of alcohol use disorders A of the use alcohol are or of them are regular They into with services when an acute health like under adolescents in with the services are are alcohol abusers or and not have long duration of alcohol use to for alcohol The of or is important as it will help us to the population 2 and in at onset of is to be noted that the as has been used in this to and chronic alcohol abuse and investigations are to for and to liver functioning at and follow-up and in alcohol use disorder and other assessment and A approach for alcohol problems may psychological and social of the The and of relapse may be with the and of the individual and the to for alcohol dependence The will the and or severity of alcohol use and severity of withdrawal Most evidence indicate of psychosocial measures with pharmacotherapy as an A treatment for has It the of the that long It may also help to of relapse from a It may help in the and may help the to to a medication treatment may the of psychosocial treatment and the made with of pharmacological treatment may be quite in the management of withdrawal the of pharmacotherapy acute alcohol withdrawal and prevention of complications such as and The of type of on the severity of withdrawal and of liver such as and are liver function is such as and should be used depending on and when are in of for a of and be to improve the prognosis such as and is the of the treatment. a case to case medication may be used or for long with interventions that help change to maintain The use of pharmacotherapy is for with dependence pharmacotherapy is also for children and adolescents with dependence have not to attempts to abstinence or have used are and in alcohol prophylaxis clinical on individual patient drug helps in decreasing or use of It alcohol in liver and in The first in high of that an physical as and or being for The severity of will on the of and alcohol has and there are of in children and adolescents as may to while being on Therefore, its use use should be to patients with under and regular specialist In patients to complete abstinence it with more of and of of liver to alcohol clinical and should be done decision to is in with patient and/or should be for a duration till the treatment have been in terms of long abstinence. of the duration of abstinence to alcohol after of This relapse to by in the It and to the of therapy, use of recent opioids it may withdrawal better in where have motivation and for medication A history of and are treatment for alcohol treatment A family history of alcohol dependence of on should be for a of to It is not associated with withdrawal on hence no should a as it may the severity of the its on of as features of or may a relapse to are of No significant in of severe in patients No with any other medication used in alcohol no risk up to and it may be an for patients not or not to that In a of on adult has been shown to have in decreasing the alcohol and of than and of alcohol per for and It may help alcohol to the risk of the health outcomes has been in the in for this in to is that it can be used as if the patient a risk of more and to the patient, their active in the treatment and is not evidence at to them in Table of disulfiram measures needs to consider the developmental and developmental while for adolescents. Most of are with interventions at motivation to change, and for adolescent problems system approach population The needs are than needs to by as much as to the needs of both and the The management should be psychosocial with in case of of Pharmacological measures should only be used under specialist only in the judgment of the the the possible the of also the of a psychiatric Therefore, a is important in with as it is related with better abstinence rates than treatment of comorbidities include not conduct and The management has been in 1: for management of alcohol use for management of use disorder The use of in of the is on and there is no to that the same is not for of use a disorder a the the frequency of use may be a better of use disorder than duration of use. It is used as or is or used as It is by various street such as that are much in than and the are also more the that use a significant risk of has This is the fact per that the of in has increased from in to in 2010. The in with an in treatment for use This is to about in counseling their with not consider it that it be to their is the of in or of The use among adolescents to health as it is associated with behaviors such as drug all of abuse sexual, and and future of not consider their use and hence their to quit this substance be The withdrawal of are as to substances like opioids and the goal of than A withdrawal of and from to significant individual differences in withdrawal assessment and of and management of intoxication, withdrawal and dependence is a work in progress and better clinical is the need of the there are no treatment for use Most adolescents not need specific medication for and like and providing information may of withdrawal and use disorder is medication like to per in for about a and to per in 2 for about a for can be given in individual should be with an medication for up to 2 the are severe or for longer than detailed psychiatric should be The should be For use no pharmacological treatment has been shown to be for such as and are used in such as and as well as treatments and have been and have demonstrated 2 the management of Management of use for management of use disorder is more common in street school conduct and are that of and it is of duration from inhalants not medical medical and/or care should be for an adolescent is has a medical condition or has physical care of should be Appropriate consultation with for and for for and for may be if be referral to The adolescent can be from care with a when the of a of to with at home till The management is short-term or and pharmacological and/or nonpharmacological. Short-term are They may for a of up to 2 to of care and medical Apart from a case of no specific pharmacotherapy has been used to Long-term there is no evidence for any it is important to patient under active follow-up with regular urine screening for substance use and regular sessions motivation and on of relapse prevention Nonpharmacological interventions Psychoeducation of patient and family with special emphasis on harm minimization like not to use inhalants or in enclosed or near a lit cigarette or there is physical and before Motivation treatment is not engagement and family and school and This be more for chronic use this substance and where other treatment options have not for street children for and can be conduct disorder and disorders should be to improve and long-term of management psychiatric disorders with of substance use, and specific medications are not required when a to self or or the are for management of tobacco use disorder substance of adult their first cigarette before the age of years adolescent cigarette use should primary prevention and of tobacco use disorders should be individualized for the This should be based medical conditions, and of the Most patients are at outpatient of various and management for tobacco use is for for treatment of various other medical or psychiatric disorders treatment of other substance use For adolescent behavioral treatments are the treatment at for pharmacotherapy in a of factors are to be considered such as and of use are no medications for adolescent are medications for the of in adults that include in the of a or as well as and in adolescent age group are to but are adult population. and of in adolescent group has shown no with were noted The only of that has been and have shown is the The may be helpful to adolescent but relapse after treatment is while the may risk of there is of data for this age data from adult are used in routine clinical The is based the severity of tobacco use. The outcomes of are better when the and duration are can be when the individual has not decided on The quit is to duration of treatment is than per are not for of and (like or may be more than a pharmacotherapy and are in adults but data on adolescents are is not in adolescent population and very have its use in this age group. use is of like and use has shown in when used in combination with and tobacco counseling in adolescence may so in adolescents with Hence, mental health should be in adolescents are being given these Long-term counseling and long-term follow-up the abstinence The treatment of comorbid psychiatric disorders such as and conduct disorder the abstinence rates in for the management of use disorder increasing use of opioids in adolescent age not treatment to on use of pharmacotherapy in this age group is increasing use of opioids in adolescence with associated in and other In India, among the drug opioids are the withdrawal scale in the severity of withdrawal and and of pharmacotherapy Apart from routine investigation, viral markers for high risk behaviors and urine screening to use and to for other substance use are required to the individualized for a of and In of suspected intoxication, should be made and as should be and the may be 2 to till no is to be considered. The of treatment needs to be made on a management for and in long-term prophylaxis is with an like It of like or for and or for and for for and or for may be required withdrawal are severe and management is it is to have management from withdrawal or with may to for the after an of and if no is of should be It is treatment of for in but in children and both and are used with considering It is a that is It is in or in combination with is to to to drug use of as is not but when For is and are is should not at after the or after the or other longer till the adolescent is not of or the withdrawal may may be treatment for adolescents with and have of abuse and and multiple but are not on opioids It may be to of the of withdrawal from treatment over has better outcomes in terms of abstinence and treatment than a treatment, it is to be used under based withdrawal management should be done in the be for a of for Long-term management The duration of varies from case to case and or more depending on the treatment for treatment duration of use, of drug use, severe dependence, social and social and an it can withdrawal in a patient used opioids Therefore, should only after the recent use of opioids opioids or and after the recent use of opioids opioids, or is to be by a urine drug is under in the and for of is also used before is or a of not any drug no for and as in It has not been in adolescents an of a of is to may be more for living in or with and to from clinical and make use of for to duration of treatment, risk of factors and treatment In in India, treatment includes an with nonpharmacological measures such as group and at follow-up all adolescents have used opioids need to be on of and with is in the first of treatment for for include severe dependence, high risk of to with the harm reduction strategy in with or with The specific of treatment include reduction of and illicit drug use, reduction of risk of of reduction of medical and risk of reduction of of social and functioning and with Nonpharmacological Psychoeducation Motivation treatment on concept of harm reduction in the of school or and for management of and use disorder in the of and are of and and A of of is important before on related problems of other are in with the guidelines to adults as there is no specific in adolescent population measures are is not suspected of other a can be used in acute severe at of over a of are required the duration of of is is established or a as to is dependence use for A the and on their and for a duration and long to in dependence attempts should be and reduction with for any or is with the it can be with the of long and can be and at and are also used to in with the use of nonpharmacological measures such as and should be at a of and to to as as In with abuse and use for should be for risk of and reduction should be done with long in an use It needs a special to its high dependence and are very in adult population and not in adolescent population For the management of intoxication, there is no specific and is mainly on For management of dependence, is same as with it is more to under Nonpharmacological management as for other SUD is important in this group as for management of use disorder on guidelines of these disorders is very to in in are part of are and The management of is care as there is no specific use an management and can be with with medical are based on the presentation with use of sedatives, and Once of psychosocial This group emphasis is made on patients under active follow-up with the help of psychosocial and than routine may be drug the of as has a and to in is suspected to where or if for example, to Table Short-term acute and long-term and It is important to the as are used in the management of the problems associated with the use of street street and SUD treatment in adolescents an to treatment include motivation to change, for self of of treatment services and that treatment is not evidence only across should choose evidence-based are with and of its to It is that treatments may have on the different substance interventions the of management high and relapse rates with SUD a chronic hence in services after an acute treatment should be as it is related to improved In treatment should be into the adolescent and family are to and trying to outcomes by among need more and of to to the needs of the adolescents from different and should of that the prevention as well as of substance use and of are no of

References

4